Thurman Alex R.
Transaction: 07/16/2026
SELL
Change
-10,000
Price
$38.68
Filing
07/21/2026
Type
SELL
Glaukos Corporation
GKOS • Medical - Devices
$177.47
▼ -2.88 (-1.60%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$10.49B
Growth
16.5%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 8.8%Manageable debt level · 0.21Healthy liquidity · 4.69Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$177.47
Change-1.60%
Shares Out58.42M
Market Cap$10.49B
Enterprise Value$10.30B
52W Range73.16 - 184.00
Beta0.75
P/E-55.77
P/S17.11
P/B15.37
P/FCF-859.95
EV/Sales16.81
Price$177.47
Change-1.60%
Shares Out58.42M
Market Cap$10.49B
Enterprise Value$10.30B
52W Range73.16 - 184.00
Beta0.75
P/E-55.77
P/S17.11
P/B15.37
P/FCF-859.95
EV/Sales16.81
EV/EBITDA-238.61
EV/FCF-844.91
Earnings Yield-1.79%
FCF Yield-0.12%
Dividend Yield0.00%
Gross Margin77.49%
Oper. Margin-17.09%
Profit Margin-36.99%
Debt/Eq0.21
Current Ratio4.69
Quick Ratio4.06
Revenue 5Y16.47%
Target$190.75
Target Upside7.48%
Target Median$195.00
Target Range150.00 - 215.00
Volume2.56M
Avg Volume1.00M
EPS Surprise0.12
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
89/100
Price Attractiveness
Cheap or expensive today
21/100
Why this score▼
Positive revenue growth · 8.8%Manageable debt level · 0.21Healthy liquidity · 4.69Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 25 analyst votes · 2026-09-03
84/100
Bullish
Bullish
18
Hold
6
Bearish
1
Price Target
2026-07-31
Low
$150.00
Mean
$186.00
Median
$192.50
High
$215.00
Insider Transactions
Recent executive and insider activity
Thurman Alex R.
Transaction: 07/16/2026
SELL
Change
-10,000
Price
$160.00
Filing
07/21/2026
Type
SELL
Thurman Alex R.
Transaction: 07/09/2026
SELL
Change
-10,000
Price
$38.68
Filing
07/13/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Thurman Alex R. | SELL | -10,000 | $38.68 | 07/16/2026 | 07/21/2026 |
| Thurman Alex R. | SELL | -10,000 | $160.00 | 07/16/2026 | 07/21/2026 |
| Thurman Alex R. | SELL | -10,000 | $38.68 | 07/09/2026 | 07/13/2026 |
| Thurman Alex R. | SELL | -10,000 | $155.00 | 07/09/2026 | 07/13/2026 |
| Thurman Alex R. | SELL | -10,000 | $38.68 | 07/06/2026 | 07/08/2026 |
| Thurman Alex R. | SELL | -10,000 | $150.00 | 07/06/2026 | 07/08/2026 |
| Navratil Tomas | SELL | -716 | $139.06 | 07/01/2026 | 07/08/2026 |
| Navratil Tomas | SELL | -483 | $142.57 | 06/25/2026 | 06/29/2026 |
| Gilliam Joseph E | SELL | -1,056 | $142.57 | 06/25/2026 | 06/29/2026 |
| Burns Thomas William | SELL | -4,059 | $142.57 | 06/25/2026 | 06/29/2026 |
| Torres Denice | BUY | +2,987 | $106.52 | 05/28/2026 | 06/23/2026 |
| Hoffmeister David F | BUY | +2,987 | $106.52 | 05/28/2026 | 06/23/2026 |
| Kliman Gilbert H | BUY | +2,987 | $106.52 | 05/28/2026 | 06/23/2026 |
| WEISNER AIMEE S | BUY | +2,987 | $106.52 | 05/28/2026 | 06/23/2026 |
| Stapley Marc | BUY | +2,987 | $106.52 | 05/28/2026 | 06/23/2026 |
| WEN LEANA | BUY | +2,987 | $106.52 | 05/28/2026 | 06/23/2026 |
| Foley Mark J | BUY | +2,987 | $106.52 | 05/28/2026 | 06/23/2026 |
| Navratil Tomas | SELL | -1,537 | $130.68 | 06/16/2026 | 06/18/2026 |
| Stapley Marc | BUY | +2,987 | $53.57 | 05/28/2026 | 06/01/2026 |
| Stapley Marc | BUY | +1,878 | Not reported | 05/28/2026 | 06/01/2026 |